pirfenidone has been researched along with Glaucoma, Open-Angle in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Wu, C; Yang, Y; Yu, M; Zeng, B; Zhu, X | 1 |
| Moon, JI; Na, JH; Shin, JA; Sung, KR | 1 |
2 other study(ies) available for pirfenidone and Glaucoma, Open-Angle
| Article | Year |
|---|---|
Inhibition of TGF-β2-Induced Trabecular Meshwork Fibrosis by Pirfenidone.
Topics: Actins; Animals; Cells, Cultured; Fibrosis; Glaucoma; Glaucoma, Open-Angle; Humans; Mice; Ocular Hypertension; Ophthalmic Solutions; Trabecular Meshwork; Transforming Growth Factor beta2 | 2023 |
Antifibrotic effects of pirfenidone on Tenon's fibroblasts in glaucomatous eyes: comparison with mitomycin C and 5-fluorouracil.
Topics: Actins; Adult; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cataract; Cell Movement; Cell Survival; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Female; Fibroblasts; Fluorouracil; Glaucoma, Open-Angle; Humans; Male; Mitomycin; Pyridones; Tenon Capsule; Trabeculectomy; Tumor Necrosis Factor-alpha | 2015 |